Else Beth Trautner
Directeur Général chez Euro-Diagnostica AB
Profil
Else Beth Trautner is currently the Co-Chief Executive Officer at Euro-Diagnostica AB since 2011 and the Director at Atlas Antibodies AB since 2015.
She previously worked as the Chief Executive Officer at Biomonitor ApS.
Postes actifs de Else Beth Trautner
| Sociétés | Poste | Début |
|---|---|---|
Euro-Diagnostica AB
 Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | Directeur Général | 02/02/2011 |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | 01/05/2015 |
Anciens postes connus de Else Beth Trautner
| Sociétés | Poste | Fin |
|---|---|---|
Biomonitor ApS
 Biomonitor ApS Medical/Nursing ServicesHealth Services Biomonitor ApS conducts research and development focusing on developing bioassays to monitor patients’ response to biological therapeutics. It offers services in the field of biopharmaceuticals, patient monitoring services through measurement of drug levels and immunogenicity of biopharmaceuticals in patients under therapy of these drugs, and customized reporter-gene cell-based assay development. The company was founded by Klaus Bendtzen and Arsalan Kharazmi on October 30, 2003 and is headquartered in Herlev, Denmark. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Euro-Diagnostica AB
Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | Health Technology |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Health Technology |
Biomonitor ApS
Biomonitor ApS Medical/Nursing ServicesHealth Services Biomonitor ApS conducts research and development focusing on developing bioassays to monitor patients’ response to biological therapeutics. It offers services in the field of biopharmaceuticals, patient monitoring services through measurement of drug levels and immunogenicity of biopharmaceuticals in patients under therapy of these drugs, and customized reporter-gene cell-based assay development. The company was founded by Klaus Bendtzen and Arsalan Kharazmi on October 30, 2003 and is headquartered in Herlev, Denmark. | Health Services |
